InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Hineline Lawrence J., Chief Financial Officer. Director active across 1 companies, notably Intra-Cellular Therapies, Inc.. In total, 6 filings have been logged. The latest transaction was disclosed on 21 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
7,454 shares
Common Stock
SEC:0001209191-22-013352:0·
10,443 shares
Common Stock
SEC:0001209191-22-012388:0·
19,639 shares
Common Stock
SEC:0001209191-22-002987:0·
19,639 shares
Common Stock
SEC:0001209191-22-002987·
€747,50550,000 shares@ €14.9501100.0% of flow
Common Stock
SEC:0001209191-21-071174·
€747,50550,000 shares@ €14.950150.0% of flow
Common Stock
SEC:0001209191-21-071174:0·
6 of 6 declarations
About Hineline Lawrence J.
Lawrence J. Hineline is the Chief Financial Officer and Senior Vice President of Finance at Intra-Cellular Therapies, Inc. He oversees the financial management of the company, including financial reporting, budgeting, and financing strategies.
